by Jason Heaviland | Mar 25, 2026
Pinpointing the Pervasive: Exposomics Analysis of Alzheimer’s Disease This poster presents a comprehensive exposomics analysis of Alzheimer’s disease, leveraging both targeted and discovery workflows to characterize environmental exposures and their biological impact....
by Jason Heaviland | Mar 2, 2026
Exposomics Measuring Chemical Drivers of Human Disease Panome Bio’s Exposomics platform enables comprehensive measurement of chemical exposures that drive human disease. Using integrated discovery (32,000+ compounds) and targeted profiling (235 priority chemicals), we...
by Jason Heaviland | Mar 2, 2026
Chemical Exposure Profiling of Alzheimer’s Patients This webinar presents a comprehensive overview of chemical exposure profiling in Alzheimer’s patients using Panome Bio’s Targeted Exposomics™ and Discovery Exposomics™ platforms. Learn how quantitative exposure...
by Jason Heaviland | Feb 27, 2026
This data report showcases Discovery Exposomics results from a study examining chemical exposure patterns associated with Alzheimer’s disease. Using Panome Bio’s expansive database of more than 32,000 environmental and exposure-related compounds, the analysis provides...
by Jason Heaviland | Feb 27, 2026
This data report presents Targeted Exposomics findings from a study investigating chemical exposure patterns linked to Alzheimer’s disease. Using highly sensitive quantitative analysis, the report outlines exposure-related biomarkers, altered chemical profiles, and...
